CRISPR Therapeutics Appoints James R. Kasinger as General Counsel – GlobeNewswire (press release)
|
CRISPR Therapeutics Appoints James R. Kasinger as General Counsel
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass., June 07, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced the … |
